Cite
HARVARD Citation
Herbreteau, L. et al. (2022). Benefice and pitfall of direct oral anticoagulants in very high-risk myeloproliferative neoplasms. Thrombosis research. pp. 25-34. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Herbreteau, L. et al. (2022). Benefice and pitfall of direct oral anticoagulants in very high-risk myeloproliferative neoplasms. Thrombosis research. pp. 25-34. [Online].